630 related articles for article (PubMed ID: 27914176)
1. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
[TBL] [Abstract][Full Text] [Related]
2. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
3. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
4. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
5. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
Wan J; Ren Y; Zhu Z; Xia L; Lu N
BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
[TBL] [Abstract][Full Text] [Related]
6. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
Shen C; Shi Y; Liang T; Su P
Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
[TBL] [Abstract][Full Text] [Related]
7. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials.
Shi N; Deng L; Altaf K; Huang W; Xue P; Xia Q
Turk J Gastroenterol; 2015 May; 26(3):236-40. PubMed ID: 26006198
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
[TBL] [Abstract][Full Text] [Related]
9. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
[TBL] [Abstract][Full Text] [Related]
10. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
[TBL] [Abstract][Full Text] [Related]
11. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
[No Abstract] [Full Text] [Related]
13. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs: A systematic review and network meta-analysis.
Oh HC; Kang H; Park TY; Choi GJ; Lehman GA
J Gastroenterol Hepatol; 2021 Jun; 36(6):1403-1413. PubMed ID: 33068012
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis.
Yaghoobi M; Rolland S; Waschke KA; McNabb-Baltar J; Martel M; Bijarchi R; Szego P; Barkun AN
Aliment Pharmacol Ther; 2013 Nov; 38(9):995-1001. PubMed ID: 24099466
[TBL] [Abstract][Full Text] [Related]
15. Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis.
Inamdar S; Han D; Passi M; Sejpal DV; Trindade AJ
Gastrointest Endosc; 2017 Jan; 85(1):67-75. PubMed ID: 27612923
[TBL] [Abstract][Full Text] [Related]
16. A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.
Siddiqui AA; Patel D; Kaplan J; Zabolotsky AH; Loren D; Kowalski T; Ghumman SS; Adler DG; Munigal S; Hayat U; Eloubeidi MA
Dig Dis Sci; 2015 Aug; 60(8):2509-15. PubMed ID: 25868629
[TBL] [Abstract][Full Text] [Related]
17. Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation: results from a randomized study with sequential biliary intubation.
Patai Á; Solymosi N; Patai ÁV
J Clin Gastroenterol; 2015; 49(5):429-37. PubMed ID: 25790233
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial.
Hosseini M; Shalchiantabrizi P; Yektaroudy K; Dadgarmoghaddam M; Salari M
Arch Iran Med; 2016 Aug; 19(8):538-43. PubMed ID: 27544361
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.
Patai Á; Solymosi N; Mohácsi L; Patai ÁV
Gastrointest Endosc; 2017 Jun; 85(6):1144-1156.e1. PubMed ID: 28167118
[TBL] [Abstract][Full Text] [Related]
20. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
